NEK10 and cancer: COSMIC analysis reveals NEK10 mutations are most present in endometrial (7.12%, n = 786), liver (10.63%, n = 2286), ovarian (7.03%, n = 967), pancreatic (7.64%, n = 2011), and skin (7.1%, n = 1786) cancers, with 21.78% of all mutations being missense substitutions.